SETTE, Giuliano
 Distribuzione geografica
Continente #
NA - Nord America 2.697
EU - Europa 587
AS - Asia 327
AF - Africa 12
SA - Sud America 12
OC - Oceania 1
Totale 3.636
Nazione #
US - Stati Uniti d'America 2.682
SG - Singapore 142
UA - Ucraina 141
IT - Italia 134
IN - India 112
SE - Svezia 99
FI - Finlandia 72
CN - Cina 68
DE - Germania 42
GB - Regno Unito 25
IE - Irlanda 19
AR - Argentina 12
BE - Belgio 12
CA - Canada 11
NL - Olanda 9
TG - Togo 8
RU - Federazione Russa 7
BG - Bulgaria 6
FR - Francia 6
RO - Romania 5
MX - Messico 4
DK - Danimarca 3
ID - Indonesia 3
GR - Grecia 2
NO - Norvegia 2
AT - Austria 1
CH - Svizzera 1
LT - Lituania 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
SA - Arabia Saudita 1
SC - Seychelles 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 3.636
Città #
Fairfield 452
Woodbridge 240
Ashburn 224
Houston 207
Seattle 183
Cambridge 172
Chandler 167
Ann Arbor 154
Wilmington 130
Singapore 99
Princeton 63
Jacksonville 58
Plano 58
Santa Clara 57
Boston 46
Lawrence 43
Rome 39
Dearborn 36
Beijing 34
San Paolo di Civitate 27
Dublin 23
Andover 22
San Diego 22
Boardman 20
Des Moines 17
Millbury 16
Norwalk 16
Helsinki 15
Brussels 12
Federal 12
Lomé 8
New York 8
Toronto 8
Redmond 7
Fasano 6
San Mateo 6
Sofia 6
Falls Church 5
Grafing 5
Nashville 5
Bremen 4
Los Angeles 4
Buffalo 3
Bühl 3
Copenhagen 3
Empoli 3
Jakarta 3
London 3
Mannheim 3
Atlanta 2
Chieti 2
Falkenstein 2
Fremont 2
Hangzhou 2
Inveruno 2
Kunming 2
Mexico City 2
Milan 2
Monza 2
Ottawa 2
Paris 2
Philadelphia 2
Pistoia 2
Pune 2
Shenyang 2
Shrewsbury 2
Southend 2
Stockholm 2
Turin 2
Alcester 1
Arzignano 1
Auburn Hills 1
Auckland 1
Basking Ridge 1
Chengdu 1
Delhi 1
Denver 1
Edinburgh 1
Ercolano 1
Ferentino 1
Frankfurt am Main 1
Fuzhou 1
Gorle 1
Grottammare 1
Guiyang 1
Hebei 1
Hefei 1
Indiana 1
Innsbruck 1
Islamabad 1
Kilburn 1
Lappeenranta 1
Mahé 1
Marrakesh 1
Miami 1
Monmouth Junction 1
Montréal 1
Moscow 1
Munich 1
Nanjing 1
Totale 2.828
Nome #
Asymmetric posterior reversible encephalopathy syndrome in patient with hyperplastic anterior choroidal artery 107
Add-on deep Transcranial Magnetic Stimulation (dTMS) for the treatment of chronic migraine. A preliminary study 91
Relapsing Long-Lasting Garcin Syndrome Revealing Skull Base Diffuse B Cell Lymphoma. The Diagnosis through the “Hartel's Route” 91
Assessment of brain tissue viability under clinical circumstances 85
Efficacy and tolerability of pregabalin as preventive treatment for migraine: a 3-month follow-up study 83
PREDICTION OF LONG-TERM OUTCOME IN THE EARLY HOURS FOLLOWING ACUTE ISCHEMIC STROKE 81
Computed tomography findings in the first few hours of ischemic stroke: implications for the clinician 81
Pathophysiology of ischemic stroke 80
Cognitive performance following carotid endarterectomy or stenting in asymptomatic patients with severe ICA stenosis 76
Acute ischemic strokes improving during the first 48 hours of onset: Predictability, outcome, and possible mechanisms a comparison with early deteriorating strokes 75
A method for the in vivo investigation of the serotonergic 5-HT2 receptors in the human cerebral cortex using positron emission tomography and 18F-labeled setoperone. 75
Hemorrhagic transformation of brain infarct: predictability in the first 5 hours from stroke onset and influence on clinical outcome 74
Clinical outcome of Acute Ischemic Stroke: Prospective Angiographic Studies 74
Orthostatic hypotension acutely impairs executive functions in Parkinson's disease 74
The use of ID migraine (TM) questionnaire in patients with multiple sclerosis 74
Focal cerebral ischaemia induces corticotropin releasing factor (CRF) vascular immunoreactivity in rat occluded hemisphere 73
The Impact of Interferon Beta and Natalizumab on Comorbid Migraine in Multiple Sclerosis 73
Specific expression of galanin in the peri-infarct zone after permanent focal cerebral ischemia in the rat 72
In vivo mapping of brain benzodiazepine receptor changes by positron emission tomography after focal ischemia in the anesthetized baboon 72
Determinants of the severity of comorbid migraine in multiple sclerosis 71
Superficial siderosis of central nervous system in patients with brachial plexus injury 70
null 70
Acute ischemic stroke therapy 69
ERGOTAMINE-INDUCED HEADACHE CAN BE SUSTAINED BY SUMATRIPTAN DAILY INTAKE 69
Primary headache and multiple sclerosis: preliminary results of a prospective study 68
Pharmacological Neuroprotection in Stroke: Rationale, State of the art and Future Directions 67
Posterior circulation infarcts simulating anterior circulation stroke: Perspective of the acute phase 66
Neurovascular Dysfunction in Alzheimer Disease. Assessment of Cerebral Vasoreactivity by Ultrasound Techniques and Evaluation of Circulating Progenitor Cells and Inflammatory Markers 66
Early (≤1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study 65
Brain energy metabolism in bilateral paramedian thalamic infarcts. A positron emission tomography study. 64
Cerebrospinal fluid isoprostane shows oxidative stress in patients with multiple sclerosis 64
Observational case-control study of the prevalence of chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. 64
REGIONAL CEREBRAL OXYGEN CONSUMPTION, BLOOD FLOW, AND BLOOD VOLUME IN HEALTHY HUMAN AGING. 63
Clinical presentation and frequency of potential sources of embolism in acute ischemic stroke patients: the experience of the Rome Acute Stroke Registry. 62
[B-mode echography in carotid pathology: correlation with morphology]. 60
Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study. 59
Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial. 58
Effect of OSAS on cerebral vasoreactivity and cIMT before and after CPAP treatment 58
Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura. 58
Chronic cerebral hypoperfusion. An undefined, relevant entity 58
Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion: a quantitative analysis of infarction volume 57
Quality of life of multiple sclerosis patients with comorbid migraine 57
Prediction of long-term outcome in the early hours following acute ischemic stroke. 56
Corticotropin-releasing factor: effect on cerebral blood flow in physiologic and ischaemic conditions 53
Malattie cerebrovascolari. 48
Hemorrhagic infarct - Reply 48
Zonisamide for Migraine Prophylaxis in Topiramate-Intolerant Patients: An Observational Study 47
null 47
Instrumental diagnosis and treatment of acute ischemic stroke: the clinician’s perspective 46
Clinical outcome of acute ischemic stroke patients with hemorragic transformation of the infarct. 44
Malattie cerebrovascolari 44
Local brain haemodynamics and oxygen metabolism in cerebrovascular disease: positron emission tomography. 41
Obsessive-compulsive and other behavioural changes with bilateral basal ganglia lesions. A neuropsychological, magnetic resonance imaging and positron tomography study. 37
TRANSCRANIAL DOPPLER EXAMINATION IN ACUTE BRAIN ISCHEMIA. 36
Electrocardiographic abnormalities within six hours of ischemic stroke. 32
Multi-Center Randomized Phase II Clinical Trial on Remote Ischemic Conditioning in Acute Ischemic Stroke Within 9 Hours of Onset in Patients Ineligible to Recanalization Therapies (TRICS-9): Study Design and Protocol 29
The therapeutical association within thrombolytic and neuroprotective drugs 29
Hypothermia during carotid endarterectomy: A safety study 23
Cerebral hemodynamics and cognitive functions in the acute and subacute stage of mild ischemic stroke: a longitudinal pilot study 22
Pharmacology of stroke: an overview 22
Relationships between high oxygen extraction fraction in the acute stage and final infarction in reversible middle cerebral artery occlusion. An investigation in anaesthetized baboons with positron emission tomography 21
The impact of cerebral vasomotor reactivity on cerebrovascular diseases and cognitive impairment 19
Revascularization pathophysiology after acute cerebral infarction 19
Hemorrhagic infarction: predictability in the first five hours from stroke and influence on clinical outcome. 18
The therapeutical association within thrombolytic and neuroprotective drugs. 16
Single-blind, randomized, pilot study combining shiatsu and amitriptyline in refractory primary headaches 14
Totale 3.785
Categoria #
all - tutte 10.608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.608


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020602 0 0 0 0 0 124 124 114 103 68 45 24
2020/2021306 35 41 8 31 23 41 2 29 29 40 20 7
2021/2022668 8 41 60 20 78 18 11 66 58 42 135 131
2022/2023578 128 118 31 62 66 72 5 17 36 19 21 3
2023/2024276 14 38 10 16 22 24 13 29 0 46 32 32
2024/2025206 18 22 29 28 59 50 0 0 0 0 0 0
Totale 3.785